Chemical inhibitors of UIMC1 function by disrupting several key processes within the DNA damage response and repair pathways. Camptothecin, for example, is a topoisomerase I inhibitor that can impede UIMC1's role in the DNA repair process. Given that UIMC1 is part of the BRCA1-A complex, which interacts with topoisomerase I, the inhibition of this enzyme leads to a decrease in the repair of DNA damage, a process where UIMC1 is involved. Similarly, etoposide and teniposide, which target topoisomerase II, also indirectly cause an accumulation of DNA damage, thus affecting UIMC1's function. These topoisomerase II inhibitors create a hostile environment for UIMC1's activity by preventing the ligation of DNA strands, which is essential for the repair of double-strand breaks.
Other inhibitors, such as mitoxantrone and amsacrine, which are known to intercalate into DNA and inhibit topoisomerase II, further exacerbate the inhibition of UIMC1. Their intercalative properties lead to the obstruction of the transcription and replication processes, thereby impeding the DNA repair function where UIMC1 is implicated. Actinomycin D operates by binding to DNA and inhibiting RNA polymerase, thus disrupting the transcription of DNA repair genes and consequently inhibiting UIMC1 function. Aphidicolin adds to this collection of inhibitors by targeting DNA polymerases, leading to disruptions in DNA replication forks, a process that UIMC1 is known to be involved in. Brefeldin A's unique mechanism of disrupting protein transport indirectly impacts UIMC1 by potentially affecting its localization and function within the DNA damage response pathway. Additionally, the PI3K inhibitors wortmannin and LY294002 disrupt the PI3K signaling pathway, which indirectly affects UIMC1 through the inhibition of PIKK family members like ATM and ATR that regulate UIMC1's activity. Finally, inhibitors such as Nu7441 and KU55933, which target DNA-PK and ATM respectively, impede the non-homologous end-joining pathway and ATM-regulated processes, both of which are crucial for UIMC1's involvement in resolving DNA damage.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
NU 7441 | 503468-95-9 | sc-208107 | 5 mg | $357.00 | 10 | |
Nu7441 is a potent inhibitor of DNA-dependent protein kinase (DNA-PK), which plays a critical role in the non-homologous end-joining (NHEJ) pathway for DNA repair. Inhibition of DNA-PK can indirectly inhibit UIMC1 by disrupting the pathway where UIMC1 participates in resolving DNA damage. | ||||||
ATM Kinase Inhibitor | 587871-26-9 | sc-202963 | 2 mg | $110.00 | 28 | |
KU55933 is an inhibitor of ATM, a PIKK family member and key regulator of the DNA damage response. By inhibiting ATM, KU55933 indirectly inhibits UIMC1's function in the DNA damage response and repair pathways, as UIMC1 is regulated by ATM-mediated signaling. | ||||||